[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

HRP960365B1 - New medicaments and the use thereof - Google Patents

New medicaments and the use thereof

Info

Publication number
HRP960365B1
HRP960365B1 HR960365A HRP960365A HRP960365B1 HR P960365 B1 HRP960365 B1 HR P960365B1 HR 960365 A HR960365 A HR 960365A HR P960365 A HRP960365 A HR P960365A HR P960365 B1 HRP960365 B1 HR P960365B1
Authority
HR
Croatia
Prior art keywords
new medicaments
medicaments
new
Prior art date
Application number
HR960365A
Other languages
English (en)
Inventor
Rolf Banholzer
Richard Reichl
Bernd Disse
Georg Speck
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of HRP960365A2 publication Critical patent/HRP960365A2/hr
Publication of HRP960365B1 publication Critical patent/HRP960365B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
HR960365A 1995-08-01 1996-07-31 New medicaments and the use thereof HRP960365B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19528145A DE19528145A1 (de) 1995-08-01 1995-08-01 Neue Arzneimittel und ihre Verwendung

Publications (2)

Publication Number Publication Date
HRP960365A2 HRP960365A2 (en) 1998-02-28
HRP960365B1 true HRP960365B1 (en) 2002-04-30

Family

ID=7768353

Family Applications (1)

Application Number Title Priority Date Filing Date
HR960365A HRP960365B1 (en) 1995-08-01 1996-07-31 New medicaments and the use thereof

Country Status (37)

Country Link
US (1) US6299861B1 (xx)
EP (1) EP0843676B1 (xx)
JP (1) JPH11510150A (xx)
KR (1) KR100445016B1 (xx)
CN (1) CN1120841C (xx)
AR (1) AR004179A1 (xx)
AT (1) ATE208390T1 (xx)
AU (1) AU6739796A (xx)
BG (1) BG63780B1 (xx)
BR (1) BR9609951A (xx)
CA (1) CA2226934C (xx)
CO (1) CO4750836A1 (xx)
CZ (1) CZ291998B6 (xx)
DE (2) DE19528145A1 (xx)
DK (1) DK0843676T3 (xx)
EE (1) EE04614B1 (xx)
ES (1) ES2167592T3 (xx)
HK (2) HK1013597A1 (xx)
HR (1) HRP960365B1 (xx)
HU (1) HU228056B1 (xx)
IL (1) IL118986A (xx)
MX (1) MX9800864A (xx)
MY (1) MY115201A (xx)
NO (1) NO317561B1 (xx)
NZ (1) NZ315645A (xx)
PL (1) PL183789B1 (xx)
PT (1) PT843676E (xx)
RO (1) RO120260B1 (xx)
RU (1) RU2171258C2 (xx)
SI (1) SI0843676T1 (xx)
SK (1) SK283260B6 (xx)
TR (1) TR199800121T1 (xx)
TW (1) TW449597B (xx)
UA (1) UA55391C2 (xx)
WO (1) WO1997005136A1 (xx)
YU (1) YU49479B (xx)
ZA (1) ZA966494B (xx)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19921693A1 (de) * 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
US20100197719A1 (en) * 1999-05-12 2010-08-05 Boehringer Ingelheim Pharma Kg Medicament compositions containing anticholinergically-effective compounds and betamimetics
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
US6787532B2 (en) 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
GB0019172D0 (en) 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6858596B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6858593B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6777400B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6750210B2 (en) 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
US6777399B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US7776315B2 (en) * 2000-10-31 2010-08-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and additional active ingredients
US20020151541A1 (en) * 2000-10-31 2002-10-17 Michel Pairet Pharmaceutical compositions containing tiotropium salts and antihistamines and their use
US20100310477A1 (en) * 2000-11-28 2010-12-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg. Pharmaceutical compositions based on anticholingerics and additional active ingredients
UA77656C2 (en) 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
US6455028B1 (en) * 2001-04-23 2002-09-24 Pharmascience Ipratropium formulation for pulmonary inhalation
AU2002303425A1 (en) * 2001-04-24 2002-11-05 Epigenesis Pharmaceuticals, Inc. Composition, formulations and kit for treatment of respiratory and lung disease with non-glucocorticoid steroids and/or ubiquinone and a bronchodilating agent
US20030018019A1 (en) * 2001-06-23 2003-01-23 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics
US20030140920A1 (en) * 2001-10-26 2003-07-31 Dey L.P. Albuterol inhalation soultion, system, kit and method for relieving symptoms of pediatric asthma
US6702997B2 (en) 2001-10-26 2004-03-09 Dey, L.P. Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
US20030191151A1 (en) * 2001-10-26 2003-10-09 Imtiaz Chaudry Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
JP2003221335A (ja) 2001-10-26 2003-08-05 Dey Lp 慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、システム、キットおよび方法
US20030203930A1 (en) * 2001-10-26 2003-10-30 Imtiaz Chaudry Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
GB0202635D0 (en) * 2002-02-05 2002-03-20 Glaxo Wellcome Mfg Pte Ltd Formulation containing novel anti-inflammatory androstane derivative
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
US20050043343A1 (en) * 2003-07-28 2005-02-24 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising an anticholinergic and a PDE IV inhibitor
US20050026948A1 (en) * 2003-07-29 2005-02-03 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising an anticholinergic and a betamimetic
US20050026882A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
US20050038004A1 (en) * 2003-07-31 2005-02-17 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
US20050101545A1 (en) * 2003-07-31 2005-05-12 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
US20090317476A1 (en) * 2003-07-31 2009-12-24 Robinson Cynthia B Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
ES2257152B1 (es) * 2004-05-31 2007-07-01 Laboratorios Almirall S.A. Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos.
PE20060826A1 (es) * 2004-12-06 2006-10-08 Smithkline Beecham Corp Derivado oleofinico de 8-azoniabiciclo[3.2.1]octano y combinacion farmaceutica que lo comprende
US20060239935A1 (en) * 2005-04-23 2006-10-26 Boehringer Ingelheim International Gmbh Compositions for inhalation
EP1879571A1 (de) * 2005-04-23 2008-01-23 Boehringer Ingelheim International GmbH Arzneimittelkombination für die inhalation enthaltend neben einem anticholinergikum ein betamimetikum und ein steroid
EP2100598A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients
TW201311649A (zh) * 2011-09-05 2013-03-16 Everlight Chem Ind Corp 用於太陽能電池電解液之化合物及其製法、含有該化合物之電解液及太陽能電池
CN111751454B (zh) * 2019-03-29 2023-12-08 天津药业研究院股份有限公司 一种异丙托溴铵中间体i的含量和有关物质的检测方法
CN110361494B (zh) * 2019-06-26 2023-08-15 四川普锐特药业有限公司 异丙托溴铵气雾剂中杂质g的检测方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3505337A (en) * 1967-12-22 1970-04-07 Boehringer Sohn Ingelheim N - hydrocarbyl-substituted noratropinium,haloalkylates and o-acyl derivatives thereof
DE2903957A1 (de) * 1979-02-02 1980-08-07 Boehringer Sohn Ingelheim Mittel zur behandlung der nasalen hypersekretion
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
DE4140861C2 (de) * 1991-12-11 2003-12-11 Boehringer Ingelheim Kg Verfahren zur Gewinnung von quartären Tropasäurealkaloiden
WO1994013263A1 (en) * 1992-12-09 1994-06-23 Jager Paul D Stabilized medicinal aerosol solution formulations

Also Published As

Publication number Publication date
CN1191535A (zh) 1998-08-26
AU6739796A (en) 1997-02-26
CN1120841C (zh) 2003-09-10
HUP9602104A2 (en) 1997-04-28
EP0843676A1 (de) 1998-05-27
CA2226934C (en) 2007-05-01
DK0843676T3 (da) 2001-12-27
HK1010879A1 (en) 1999-07-02
AR004179A1 (es) 1998-11-04
NZ315645A (en) 1999-11-29
EE9800028A (et) 1998-08-17
RU2171258C2 (ru) 2001-07-27
SK11298A3 (en) 1998-07-08
ZA966494B (en) 1997-02-03
PT843676E (pt) 2002-04-29
IL118986A (en) 1998-12-06
BG102202A (en) 1998-09-30
US6299861B1 (en) 2001-10-09
IL118986A0 (en) 1996-10-31
NO317561B1 (no) 2004-11-15
YU49479B (sh) 2006-05-25
DE59608156D1 (de) 2001-12-13
CZ225396A3 (cs) 1998-03-18
CZ291998B6 (cs) 2003-07-16
SI0843676T1 (en) 2002-06-30
EP0843676B1 (de) 2001-11-07
BR9609951A (pt) 1999-02-02
HK1013597A1 (en) 1999-09-03
JPH11510150A (ja) 1999-09-07
DE19528145A1 (de) 1997-02-06
UA55391C2 (uk) 2003-04-15
RO120260B1 (ro) 2005-11-30
MX9800864A (es) 1998-04-30
PL183789B1 (pl) 2002-07-31
SK283260B6 (sk) 2003-04-01
TW449597B (en) 2001-08-11
KR100445016B1 (ko) 2004-11-08
ATE208390T1 (de) 2001-11-15
MY115201A (en) 2003-04-30
HU228056B1 (en) 2012-09-28
YU44596A (sh) 1998-12-23
HU9602104D0 (en) 1996-09-30
CA2226934A1 (en) 1997-02-13
HUP9602104A3 (en) 2000-03-28
KR19990035997A (ko) 1999-05-25
TR199800121T1 (xx) 1998-04-21
NO980424D0 (no) 1998-01-30
ES2167592T3 (es) 2002-05-16
PL324804A1 (en) 1998-06-22
BG63780B1 (bg) 2002-12-29
WO1997005136A1 (de) 1997-02-13
HRP960365A2 (en) 1998-02-28
CO4750836A1 (es) 1999-03-31
EE04614B1 (et) 2006-04-17
NO980424L (no) 1998-01-30

Similar Documents

Publication Publication Date Title
HRP960365B1 (en) New medicaments and the use thereof
GB9419536D0 (en) Medicaments
GB2304309B (en) Laminate and use thereof
GB9406573D0 (en) Medicaments
GB9420784D0 (en) Medicaments
IL130348A0 (en) Imidazopyridazines and medicaments containing the same
HUP9903715A3 (en) 25-hydroxy-16-ene-26,27-bishomo-cholecalciferols, their use and medicaments containing them
AU3982695A (en) Oxazolyl- and thiazolylimidazo-benzo- and thienodiazepines and their use as medicaments
ZA955128B (en) Novel amido-quinoxalinediones the preparation and use thereof
GB9418530D0 (en) Medicaments
GB9411052D0 (en) Medicaments
GB9421133D0 (en) Medicaments
GB9416365D0 (en) Medicaments
GB9424013D0 (en) Medicaments
EP0790829A4 (en) DRUG
HU0001008D0 (en) 2,3-cyclic-condensed-1,4-dihydro-pyridine-derivatives and medicaments containing the same
GB9419434D0 (en) Pharmaceutical use
GB9406049D0 (en) Pharmaceutical use
GB9402188D0 (en) Pharmaceutical use
GB9422159D0 (en) New pharmaceutical use
GB9405195D0 (en) New pharmaceutical use
GB9405198D0 (en) New pharmaceutical use
GB9421156D0 (en) New pharmaceutical use
ZA963998B (en) 3,4-Disubstituted-phenylsulphonamides and their therapeutic use
ZA963999B (en) 3,4-Disubstituted-phenylsulphonamides and their therapeutic use

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20150702

Year of fee payment: 20

PB20 Patent expired after termination of 20 years

Effective date: 20160731